TOP TIERMARKET NEWSWIRE
News & sentiment

BLOSSOMHILL THERAPEU (BLSM) — News & AI sentiment

BLOSSOMHILL THERAPEU (BLSM) news roundup. 7 stories in the past week, 20 over 30 days. Average 30-day sentiment is 61.8/100. Recent insider activity (SEC Form 4, 90-day window): 6 purchases totalling $25.2M and 0 sales totalling $0 — net buying of $25.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
7
avg sentiment 62.7/100
30d stories
20
avg sentiment 61.8/100
Insider net (90d)
$25.2M
6 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

BLSM news in the last 24 hours, 7 days, 30 days and 90 days

How much BLSM coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowBLSM storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days762.7/100BLSM headlines →
Last 30 days2061.8/100BLSM headlines →
Last 90 days3554.7/100BLSM headlines →

Latest stories on BLSM

1d ago
3d ago
3d ago
Why is BlossomHill Therapeutics stock rallying today?
Investing.com Markets50 · neutralgeneral
3d ago
3d ago
3d ago
3d ago
Sep 3
Sep 3
Sep 1
Sep 1
Sep 1
Sep 1
Sep 1
Sep 1
Sep 1
JPMorgan initiates BlossomHill Therapeutics stock with overweight
Investing.com Analyst Ratings61 · neutralanalyst
Sep 1
Aug 31
Aug 31
Aug 18
Aug 18
Aug 18
Aug 10
Aug 7
Aug 7
Open BLSM in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →